InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Van Nostrand Robert l, 董事. Director active across 4 companies, notably Intra-Cellular Therapies, Inc.. Aggregated, 32 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €13k. Activity tracked since 30 June 2021. The latest transaction was filed on 7 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Van Nostrand Robert l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报32 总计
50,000 股0Common StockSEC:0001104659-26-002511:0
10,000 股@ US$1.48100.0% 占其流量Common StockSEC:0001104659-25-059166:0
标准退出：2025年9月10日 (T+90)
11,340 股@ US$132.0055.3% 占其流量Common StockSEC:0000950170-25-049636:0
12,500 股0Common StockSEC:0001104659-25-003497:0
83 股@ US$68.490.2% 占其流量Common StockSEC:0000950170-24-080987:0
1,567 股Common StockSEC:0000950170-24-077472:0
20,000 股@ US$16.8612.6% 占其流量Common StockSEC:0000950170-24-076380:0
79 股@ US$69.200.2% 占其流量Common StockSEC:0000950170-24-040166:0
11,924 股0Common StockSEC:0001628280-24-013923:0
20,000 股@ US$18.5613.8% 占其流量Common StockSEC:0000950170-24-022485:0
6,000 股0Common StockSEC:0001104659-24-006381:0
18,879 股0Common StockSEC:0001628280-24-000210:0
76 股@ US$71.620.2% 占其流量Common StockSEC:0000950170-24-001303:0
105 股@ US$52.090.2% 占其流量Common StockSEC:0001209191-23-051143:0
13,868 股0Common StockSEC:0001121702-23-000056:0
85 股@ US$63.320.2% 占其流量Common StockSEC:0001209191-23-041084:0
2,040 股0Common StockSEC:0001628280-23-024201:0
10,000 股@ US$13.054.8% 占其流量Common StockSEC:0001209191-23-024899:0
95 股@ US$54.150.2% 占其流量Common StockSEC:0001209191-23-022799:0
1,642 股0Common StockSEC:0001628280-23-010704:0
2,500 股0Common StockSEC:0001104659-23-010623:0
97 股@ US$52.920.2% 占其流量Common StockSEC:0001209191-23-000197:0
110 股@ US$46.530.2% 占其流量Common StockSEC:0001209191-22-052716:0
20,000 股@ US$12.459.7% 占其流量Common StockSEC:0001209191-22-045685:0
108 股@ US$57.080.2% 占其流量Common StockSEC:0001209191-22-040571:0
32 条申报中的 25 条
About Van Nostrand Robert l
VAN NOSTRAND ROBERT L is a Director and has 32 filings in total. In the 32 recent filings we hold, the reported amounts are EUR 12,758 for buys and EUR 1,372,190 for sells, with a date range from 2016-01-05 to 2026-01-09. The companies mentioned are Intra-Cellular Therapies, Inc., SELLAS Life Sciences Group, Inc., YIELD10 BIOSCIENCE, INC. and Enumeral Biomedical Holdings, Inc., and the most common transaction nature is Attribution.
